Latest News Archive

Please select Category, Year, and then Month to display items

Fighting COVID-19: Here is how we are helping

16 April 2020 | Story Department of Communication and Marketing | Photo Charl Devenish

Farmovs — In 2019, FARMOVS was pre-qualified by the WHO to support clinical studies aimed at improving access to quality generic medicines across the globe.

The University of the Free State (UFS) is committed to supporting government’s efforts to overcome the COVID-19 pandemic. During this challenging time, dedicated staff members at the UFS continue to provide services as a testimony to their commitment to advance public knowledge of COVID-19 for the greater good of South Africa.

The following is a synopsis of the areas in which the UFS is actively assisting.

Public Health Emergency Solidarity Trial
Clinicians from the Department of Internal Medicine, the Department of Critical Care, and the Division of Virology will be working with FARMOVS to participate in the Public Health Emergency Solidarity Trial initiated by the World Health Organization (WHO). This international randomised trial will evaluate four treatment options (remdesivir, lopinavir/ritonavir, lopinavir/ritonavir plus interferon, chloroquine or hydroxychloroquine) for the treatment of COVID-19.

The trial is expected to include more than 45 countries worldwide, including a number of South African sites.

Farmovs
FARMOVS is in a planning process to support all the Bloemfontein hospitals, including Pelonomi, Universitas, 3 Military Hospital, Mediclinic, and Rosepark, in conducting the largest global trial on COVID-19 – the Public Health Emergency Solidarity Trial, under leadership of the WHO.

Negotiations are ongoing between the UFS and the Department of Health in the Free State for FARMOVS to offer support with the continuation of healthcare to non-COVID-19 patients in an attempt to free up space at Universitas Hospital for isolation of COVID-19 patients.

In 2019, FARMOVS was pre-qualified by the WHO to support clinical studies aimed at improving access to quality generic medicines across the globe. FARMOVS also receives feasibility requests for support with the evaluation of existing drugs (repurposing) as well as the development of novel drugs for the treatment of COVID-19 – this is an ongoing process.

Disaster Management Training and Education Centre (DiMTEC)
DiMTEC represents the UFS on the Provincial Joint Operation Centre (PROVJOC). The PROVJOC is a fully equipped, dedicated facility that is proactively established to enable all relevant role players /disciplines to jointly manage all safety and security-related aspects of any planned event or any major incident which has occurred or is imminent – especially in the response and recovery operations phase – at the strategic and/or tactical level, using the Unified Command System. This facility is also linked to all other established safety and security centres.

Research and Innovation
The UFS hosts a SARChI Research Chair in vector-borne and zoonotic diseases, and recently invested in the establishment of a biosafety level-3 facility. Hence, there is expertise on the campus to plan and conduct research on zoonotic and medically significant viruses. In addition, there are research groups focusing on protein expression systems with potential for utilisation in the development of diagnostic assays with application in either diagnosis or surveillance.

Currently, researchers at the UFS have established several projects that will contribute directly towards the COVID-19 outbreak.

News Archive

Business leaders impressed with our university

2011-08-18

David Nkwenkweza, an employee of the Unit for Students with Disabilities at the UFS, with from the left: Gerhard Joubert, Head: Group Marketing and Stakeholder Relations at PPS Insurance; Tsholo Diale, Corporate Social Investment Manager at Afrisam, and Mpho Letlapo CEO of the Sasol Inzalo Fund
Photo: Phelekwa Mpono

Business leaders from some of South Africa’s top companies visited our Bloemfontein Campus on Tuesday, 16 August 2011. Business leaders, which included chief executive officers (CEOs) and top managers from companies, such as Intel, First National Bank and Mediclinic flew in from Johannesburg. They were taken on a trip around campus, meeting university staff and students.

The purpose of the visit was to introduce them to the UFS and some of its projects. It was furthermore to share ideas about what role the university need to play in preparing future leaders for the market place.

Walking around campus, the group of business leaders visited the different faculties, some departments, as well as the bustling Thakaneng Student Centre.

Ms Mpho Lethlapo, CEO of the Sasol Inzalo Fund, said the UFS campus was different from what she had envisioned. She was impressed with our Unit for Students with Disabilities and said the outstanding facilities at the unit were a necessity as people with disabilities form part of society.

Mr Pule Mokoena, Group Executive: Sales and Marketing of Innovation said his trip to the university was an eye-opener as he had certain perceptions about the university. He expressed admiration towards Prof. Jonathan Jansen, Vice-Chancellor and Rector, and said his outlook towards learning was commendable. Mr Mokoena furthermore said the people on the UFS campus were more open-minded than what he had expected and said everywhere he went staff said they only wanted what was best for their students. According to Mr Mokoena, Kovsie students are the type of graduates business leaders want to employ.

Back

Economic and Management Sciences

Education

Health Sciences

The Humanities

Law

Natural and Agricultural Sciences

Theology and Religion

Open Distance Learning

Business School

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept